Introduction {#sec1}
============

The incorporation of the trifluoromethylthio group (CF~3~S−) into organic molecules can substantially alter their physical, chemical, and biological properties due to its high lipophilicity and strong electronegativity.^[@ref1]^ Therefore, trifluoromethylthiolated compounds are widely used in pharmaceuticals, agrochemicals, and functional materials.^[@ref2]^ Recently, considerable effort has been devoted to the development of new and efficient methods for introducing the CF~3~S group into heteroarenes with different CF~3~S sources.^[@ref3]^ Up to now, a broad range of important heterocycles, such as pyrrole,^[@ref4]^ oxindole,^[@ref5]^ indole,^[@ref6]^ indanone,^[@ref7]^ coumarin,^[@ref8]^ quinone,^[@ref9]^ chromone,^[@ref10]^ and benzofuran(thiophene),^[@ref11]^ have been successfully trifluoromethylthiolated using various nucleophilic, electrophilic, and radical trifluoromethylthiolating reagents. However, to the best of our knowledge, only two examples on trifluoromethylthiolation of pyrazolin-5-one have been reported ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref12]^

![Examples of Trifluoromethylthiolation of Pyrazolin-5-one](ao-2017-01453a_0001){#sch1}

Trifluoromethanesulfenamide (PhNHSCF~3~), a stable and easily handled trifluoromethylthiolating reagent,^[@ref13]^ can be used as an electrophilic source for the trifluoromethylthiolation of a variety of nucleophiles, such as allylsilanes,^[@ref14]^ electron-rich arenes,^[@ref15]^ hexahydropyrrolo\[2,3-*b*\]indoles,^[@ref16]^ alkenes,^[@ref17]^ alkynes,^[@ref18]^ and Grignard and lithium reagents.^[@ref19]^

Pyrazolin-5-ones have received a great deal of attention because they exhibit important biological properties.^[@ref20]^ Specifically, 5-hydroxyprazoles have found many applications in pharmaceuticals and agrochemicals ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref21]^ Consequently, many methods have been developed for the synthesis of new structurally diverse 5-hydroxyprazole derivatives.^[@ref22]^ In continuation of our interest in new reaction of pyrazolin-5-ones and trifluoromethylthiolation reaction,^[@ref23]^ in this study, we reported an efficient method for the synthesis of trifluoromethylthiolated 5-hydroxy-1*H*-pyrazole derivatives by reaction of pyrazolin-5-ones with PhNHSCF~3~ in the presence of BiCl~3~ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Examples of biologically active hydroxyprazole derivatives.](ao-2017-01453a_0006){#fig1}

Results and Discussion {#sec2}
======================

We began our exploration by using the reaction of 3-methyl-1-phenyl-1*H*-pyrazol-5(4*H*)-one **1a** with PhNHSCF~3~**2** as the model reaction to optimize the reaction conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). No desired product was observed when the reaction was performed in the absence of an acid (entry 1). Generally, trifluoromethylthiolation with PhNHSCF~3~ was proposed to be initiated by the addition of acids.^[@ref24]^ Thus, we initially investigated various Brönsted acids and Lewis acids for the electrophilic trifluoromethylthiolation of pyrazolin-5-ones (entries 2--11). It was found that the most commonly employed initiators, such as CH~3~COCl, TsOH, and BF~3~·Et~2~O,^[@ref14],[@ref16]^ gave the desired SCF~3~ product **3a** only in 15, 19, and 30% yields, respectively (entries 5--7). Delightfully, the yield increased significantly to 92% when Lewis acid BiCl~3~ was used as the initiator (entry 11). Screening of the solvents indicated that 1,2-dichloroethane (DCE) was the best choice and reaction in dichloromethane (DCM) was less effective (entries 11 and 14). No reaction occurred in aprotic polar solvents, such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF) (entries 12 and 13). Moreover, the amounts of PhNHSCF~3~**2** and BiCl~3~ added have important influence on the reaction yields. Both optimal amounts of PhNHSCF~3~**2** and BiCl~3~ were found to be 2.0 equiv (entry 11). Further increasing or decreasing their amounts led to reduced yields (entries 15--18). The influence of reaction temperature was also examined, and it was found that performing the reaction at 80 °C was optimal for the reaction, whereas the yield decreased at both higher and lower temperatures (entries 11, 19, and 20).

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-01453a_0002){#fx1}

  entry   **2** (equiv)   acid (equiv)         solvent   temp (°C)   **3a** (%)[b](#t1fn2){ref-type="table-fn"}
  ------- --------------- -------------------- --------- ----------- --------------------------------------------
  1       2.0             none                 DCE       80          0
  2       2.0             CF~3~COOH (2.0)      DCE       80          0
  3       2.0             TsCl (2.0)           DCE       80          0
  4       2.0             TfOH (2.0)           DCE       80          10
  5       2.0             CH~3~COCl (2.0)      DCE       80          15
  6       2.0             TsOH (2.0)           DCE       80          19
  7       2.0             BF~3~·Et~2~O (2.0)   DCE       80          30
  8       2.0             CuCl (2.0)           DCE       80          0
  9       2.0             CuCl~2~ (2.0)        DCE       80          0
  10      2.0             FeCl~3~ (2.0)        DCE       80          42
  11      2.0             BiCl~3~ (2.0)        DCE       80          92
  12      2.0             BiCl~3~ (2.0)        DMSO      80          0
  13      2.0             BiCl~3~ (2.0)        DMF       80          0
  14      2.0             BiCl~3~ (2.0)        DCM       80          70
  15      1.5             BiCl~3~ (2.0)        DCE       80          79
  16      2.5             BiCl~3~ (2.0)        DCE       80          89
  17      2.0             BiCl~3~ (1.5)        DCE       80          72
  18      2.0             BiCl~3~ (2.5)        DCE       80          89
  19      2.0             BiCl~3~ (2.0)        DCE       60          51
  20      2.0             BiCl~3~ (2.0)        DCE       100         90

Reaction conditions: **1a** (0.25 mmol), solvent (1 mL), 12 h.

Yields were determined by gas chromatography--mass spectrometry analysis and based on **1a**.

With the optimal reaction conditions in hand ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11), the generality and limitation of this BiCl~3~-promoted trifluoromethylthiolation of various pyrazolin-5-ones were investigated ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The results indicated that when the R^1^ substituents at the 3-position of pyrazolin-5-ones were alkyl group (**1a**--**d**) and phenyl group (**1g**, R^1^ = C~6~H~5~), the reaction proceeded smoothly and gave the corresponding CF~3~S-containing products in high yields. Changing the methyl group at the 3-position of pyrazolin-5-one to the trifluoromethyl group (**1f**, R^1^ = CF~3~) resulted in diminished product yield (**3f**). In addition, the sterically hindered 3-substituted pyrazolin-5-one **1e** could also furnish the desired product (**3e**) in moderate yield.

###### Substrate Scope of Pyrazolin-5-ones[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao-2017-01453a_0004){#fx2}

Reaction conditions: **1a**--**n** (0.5 mmol), BiCl~3~ (1.0 mmol), PhNHSCF~3~ (1.0 mmol), DCE (2 mL), Ar, 80 °C.

Isolated yields.

The scope of the R^2^ substituent was then subsequently examined. Generally, the substrate bearing electron-poor aryl group (R^2^) at the 1-position of pyrazolin-5-one nitrogen atom afforded higher yields than those substrates having electron-rich aryl group (**3i** versus **3h**). The position of the substituent on the benzene ring of pyrazolin-5-one has an obvious influence on the yields of the reaction. Pyrazolin-5-one possessing para- and ortho-substituted aryl group (R^2^ group) provided the trifluoromethylthiolated products in excellent yield (**3k** and **3l**), whereas the yield was reduced when pyrazolin-5-one with meta-substituted aryl group was used as substrate (**1m**). Importantly, halogen groups (F, Cl, and Br) in the pyrazolin-5-ones were well tolerated (**1i**--**m**), which provided opportunities for further modification. Gratifyingly, 1,3-dimethyl-1*H*-pyrazol-5(4*H*)-one (**1n**) also exhibited extraordinary reactivity and afforded trifluoromethylthiolation product in excellent yield. Unfortunately, both substrates having strong electron-donating group (CH~3~O) and electron-withdrawing group (CN) on benzene ring (R^2^ group) failed to afford the expected trifluoromethylthiolated products.

On the basis of the above experimental results and related literatures,^[@ref14],[@ref25]^ a plausible mechanism for the BiCl~3~-promoted trifluoromethylthiolation of pyrazolin-5-ones is depicted in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. First, trifluoromethanesulfenamide **2** is activated by bismuth(III) chloride to afford trifluoromethanesulfanyl cation (CF~3~S^+^). Pyrazolin-5-one **1** undergoes keto--enol tautomerization to form intermediate **I**. Subsequently, the addition of CF~3~S^+^ to the enolate of pyrazolin-5-one **I** furnishes intermediate **II**. Finally, the loss of a proton from **II** results in the formation of the desired trifluoromethylthiolated product **3**. Noticeably, the corresponding keto tautomer **III** is not observed.

![Proposed Reaction Mechanism](ao-2017-01453a_0005){#sch2}

Conclusions {#sec3}
===========

In summary, we have developed a novel and efficient bismuth(III)-promoted trifluoromethylthiolation of pyrazolin-5-ones using PhNHSCF~3~ as an electrophilic source of CF~3~S^+^. The reactions proceeded smoothly and furnished the corresponding trifluoromethylthiolated 5-hydroxy-1*H*-pyrazole derivatives in fair to excellent yields. The present results expand the scope and utility of electrophilic trifluoromethylthiolating agent PhNHSCF~3~.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reagents were of analytical grade, obtained from commercial suppliers, and used without further purification. All pyrazolones were prepared according to previously reported procedures.^[@ref26]−[@ref28]^ Melting points were measured in an open capillary using Büchi melting point B-540 apparatus and are uncorrected. ^1^H NMR and ^13^C NMR spectra were recorded on 400 and 100 MHz spectrometers, respectively, using tetramethylsilane as internal standard. The ^19^F NMR spectra were obtained using a 400 spectrometer (376 MHz). DMSO-*d*~6~ was used as the NMR solvents. High-resolution mass spectra (HRMS) were acquired in the electron ionization (EI) mode using a time-of-flight mass analyzer. Silica gel (300--400 mesh size) was used for column chromatography. Thin-layer chromatography (TLC) analysis of reaction mixtures was performed using silica gel plates.

Experimental Procedures and Spectral Data {#sec4.2}
-----------------------------------------

### General Procedure for the Synthesis of **3a**--**n** {#sec4.2.1}

A solution of pyrazolones **1a**--**n** (0.5 mmol), PhNHSCF~3~ (193 mg, 1.0 mmol), and BiCl~3~ (315 mg, 1.0 mmol) in DCE (2 mL) was stirred at 80 °C under argon atmosphere for about 12 h (monitored by TLC). After the completion of reaction, the reaction mixture was quenched with H~2~O (20 mL) and then extracted with ethyl acetate (10 mL × 3). The organic layer was separated and dried over Na~2~SO~4~. The solvent was concentrated in vacuo. The crude product was purified by column chromatography on silica gel using *n*-hexane/ethyl acetate (10/1) (1% formic acid was added) as eluent to afford the pure target compounds **3a**--**n**.

### 3-Methyl-1-phenyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3a**) {#sec4.2.2}

White solid (85%, 116.5 mg); mp 64.4--65.6 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.85 (d, *J* = 8.0 Hz, 2H), 7.40 (t, *J* = 7.6 Hz, 2H), 7.21--7.17 (m, 1H), 5.98 (s, 1H), 2.20 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 160.4, 152.0, 138.7, 129.5 (q, ^1^*J*~CF~ = 309.6 Hz), 128.6, 124.8, 120.0, 78.0, 12.4; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −45.3 (s, 3F); HRMS (EI): calcd for C~11~H~9~F~3~N~2~OS \[M\]^+^: 274.0388, found: 274.0386.

### 3-Ethyl-1-phenyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3b**) {#sec4.2.3}

White solid (84%, 121.0 mg); mp 67.3--68.9 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.73 (d, *J* = 8.0 Hz, 2H), 7.51 (t, *J* = 7.6 Hz, 2H), 7.32 (t, *J* = 6.8 Hz, 1H), 2.67 (q, *J* = 7.5 Hz, 2H), 1.25 (t, *J* = 7.6 Hz, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 156.8, 137.7, 129.2 (q, ^1^*J*~CF~ = 309.0 Hz), 129.0, 126.2, 121.3, 118.2, 79.2, 19.6, 12.3; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~12~H~11~F~3~N~2~OS \[M\]^+^: 288.0544, found 288.0543.

### 3-Isopropyl-1-phenyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3c**) {#sec4.2.4}

White solid (83%, 125.2 mg); mp 73.2--75.0 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.71 (d, *J* = 8.0 Hz, 2H), 7.50 (t, *J* = 8.0 Hz, 2H), 7.33 (t, *J* = 7.4 Hz, 1H), 3.17--3.10 (m, 1H), 1.27 (d, *J* = 7.2 Hz, 6H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 160.2, 137.9, 129.1 (q, ^1^*J*~CF~ = 309.3 Hz), 128.9, 126.3, 121.5, 26.0, 21.4; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.7 (s, 3F); HRMS (EI): calcd for C~13~H~13~F~3~N~2~OS \[M\]^+^: 302.0701, found: 302.0700.

### 1-Phenyl-3-propyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3d**) {#sec4.2.5}

White solid (90%, 135.9 mg); mp 70.1--72.3 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.72 (d, *J* = 7.6 Hz, 2H), 7.50 (t, *J* = 8.0 Hz, 2H), 7.32 (t, *J* = 7.4 Hz, 1H), 2.61 (t, *J* = 7.6 Hz, 2H), 1.74--1.65 (m, 2H), 0.96 (t, *J* = 7.4 Hz, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 155.5, 137.7, 129.1 (q, ^1^*J*~CF~ = 309.2 Hz), 129.0, 126.2, 121.2, 28.1, 21.0, 13.7; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~13~H~13~F~3~N~2~OS \[M\]^+^: 302.0701, found: 302.0702.

### 1-Phenyl-3-*tert*-butyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3e**) {#sec4.2.6}

White solid (79%, 124.8 mg); mp 72.8--73.6 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.72 (d, *J* = 8.0 Hz, 2H), 7.50 (t, *J* = 8.0 Hz, 2H), 7.31 (t, *J* = 8.0 Hz, 1H), 2.51 (s, 1H), 1.39 (s, 9H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 160.5, 157.4, 138.0, 129.1 (q, ^1^*J*~CF~ = 309.3 Hz), 129.0, 126.4, 121.6, 77.6, 33.8, 29.3; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −43.8 (s, 3F); HRMS (EI): calcd for C~14~H~15~F~3~N~2~OS \[M\]^+^: 316.0857, found: 316.0859.

### 1-Phenyl-3-(trifluoromethyl)-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3f**) {#sec4.2.7}

White solid (65%, 106.6 mg); mp 55.2--56.9 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 8.06 (d, *J* = 6.8 Hz, 2H), 7.36 (t, *J* = 8.0 Hz, 2H), 7.11 (t, *J* = 7.4 Hz, 1H), 3.62 (s, 1H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 165.5, 142.1 (q, ^2^*J*~CF~ = 33.5 Hz), 140.8, 129.3 (q, ^1^*J*~CF~ = 311.2 Hz), 128.3, 127.8, 121.6 (q, ^1^*J*~CF~ = 268.4 Hz), 123.3, 118.3; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −45.9 to −46.0 (m, 3F), −61.62 to −61.64 (m, 3F); HRMS (EI): calcd for C~11~H~6~F~6~N~2~OS \[M\]^+^: 328.0105, found: 328.0106.

### 1,3-Diphenyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3g**) {#sec4.2.8}

White solid (83%, 139.4 mg); mp 75.2--76.1 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.95--7.86 (m, 4H), 7.54--7.41 (m, 5H), 7.36--7.33 (m, 1H), 4.08 (s, 1H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 158.5, 151.9, 138.3, 132.2, 129.0, 128.5, 128.3, 127.5, 126.4, 121.5, 118.2, 77.7; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~16~H~11~F~3~N~2~OS \[M\]^+^: 336.0544, found: 336.0545.

### 3-Methyl-1-(*p*-methylphenyl)-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3h**) {#sec4.2.9}

White solid (80%, 115.2 mg); mp 67.8--69.3 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.57 (d, *J* = 8.4 Hz, 2H), 7.28 (d, *J* = 8.4 Hz, 2H), 2.33 (s, 3H), 2.24 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 157.9, 152.8, 136.9, 130.8, 129.2 (q, ^1^*J*~CF~ = 309.0 Hz), 122.5, 118.4, 80.3, 12.8, 12.1; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~12~H~11~F~3~N~2~OS \[M\]^+^: 288.0544, found: 288.0545.

### 1-(4-Fluorophenyl)-3-methyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3i**) {#sec4.2.10}

White solid (90%, 131.4 mg); mp 60.3--61.5 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.74--7.71 (m, 2H), 7.33--7.29 (m, 2H), 2.23 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 160.0 (d, ^1^*J*~CF~ = 242.1 Hz), 157.5, 152.2, 134.0, 129.2 (q, ^1^*J*~CF~ = 309.0 Hz), 123.3 (d, ^3^*J*~CF~ = 8.4 Hz), 115.7 (d, ^2^*J*~CF~ = 22.7 Hz), 79.9, 12.0; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.9 (s, 3F), −115.90 to −115.94 (m, 1F); HRMS (EI): calcd for C~11~H~8~F~4~N~2~OS \[M\]^+^: 292.0293, found: 292.0296.

### 1-(4-Bromophenyl)-3-methyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3j**) {#sec4.2.11}

White solid (90%, 159.3 mg); mp 86.9--87.7 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.74 (d, *J* = 8.8 Hz, 2H), 7.60 (d, *J* = 8.8 Hz, 2H), 2.19 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 157.8, 152.8, 136.9, 131.9, 129.2 (q, ^1^*J*~CF~ = 309.6 Hz), 122.5, 118.4, 80.3, 12.1; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~11~H~8~BrF~3~N~2~OS \[M\]^+^: 351.9493, found: 353.9479.

### 1-(4-Chlorophenyl)-3-methyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3k**) {#sec4.2.12}

White solid (90%, 138.6 mg); mp 79.3--79.9 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.81 (d, *J* = 8.8 Hz, 2H), 7.51 (d, *J* = 8.8 Hz, 2H), 2.22 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 158.8, 152.6, 136.9, 129.3 (q, ^1^*J*~CF~ = 309.2 Hz), 129.6, 128.8, 121.9, 79.3, 12.2; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −45.0 (s, 3F); HRMS (EI): calcd for C~11~H~8~ClF~3~N~2~OS \[M\]^+^: 307.9998, found: 308.0000.

### 1-(2-Chlorophenyl)-3-methyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3l**) {#sec4.2.13}

White solid (88%, 135.5 mg); mp 80.0--81.3 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.65 (d, *J* = 7.6 Hz, 1H), 7.52--7.46 (m, 3H), 2.22 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 158.8, 152.2, 134.8, 131.3, 130.7, 130.0, 130.0, 129.3 (q, ^1^*J*~CF~ = 309.1 Hz), 127.9, 78.1, 12.1; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −45.0 (s, 3F); HRMS (EI): calcd for C~11~H~8~ClF~3~N~2~OS \[M\]^+^: 307.9998, found: 308.0000.

### 1-(3-Chlorophenyl)-3-methyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3m**) {#sec4.2.14}

White solid (70%, 107.8 mg); mp 81.2--81.9 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.81--7.80 (m, 1H), 7.74--7.72 (m, 1H), 7.49 (t, *J* = 8.0 Hz, 1H), 7.35--7.32 (m, 1H), 2.24 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 158.3, 153.1, 138.7, 133.3, 130.7, 129.2 (q, ^1^*J*~CF~ = 309.0 Hz), 125.6, 120.0, 118.8, 80.6, 12.0; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −44.8 (s, 3F); HRMS (EI): calcd for C~11~H~8~ClF~3~N~2~OS \[M\]^+^: 307.9998, found: 308.0000

### 1,3-Dimethyl-4-((trifluoromethyl)thio)-1*H*-pyrazol-5-ol (**3n**) {#sec4.2.15}

White solid (92%, 97.5 mg); mp 50.3--50.5 °C; ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 3.47 (s, 3H), 2.11 (s, 3H); ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 156.8, 149.8, 129.3 (q, ^1^*J*~CF~ = 308.9 Hz), 77.5, 33.1, 11.9; ^19^F NMR (376 MHz, DMSO-*d*~6~) δ −45.4 (s, 3F); HRMS (EI): calcd for C~6~H~7~F~3~N~2~OS \[M\]^+^: 212.0231, found: 212.0232.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b01453](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b01453).Copies of NMR and HRMS spectra for new compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01453/suppl_file/ao7b01453_si_001.pdf))

Supplementary Material
======================

###### 

ao7b01453_si_001.pdf

The authors declare no competing financial interest.

The authors are grateful to the financial support from the National Natural Science Foundation of China (Grant Nos. 21472043 and 21302128).
